DULAGLUTIDE LAUNCHED IN THE UK AS DIABETES TREATMENT

The pharmaceutical journal group

首页> 外文期刊>The pharmaceutical journal >DULAGLUTIDE LAUNCHED IN THE UK AS DIABETES TREATMENT

【24h】

DULAGLUTIDE LAUNCHED IN THE UK AS DIABETES TREATMENT

机译：DULAGLUTIDE在糖尿病治疗中在英国上市

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The second once-weekly non-insulin injection for patients with type 2 diabetes became available in the UK from 13 January 2015. Modified release dulaglutide (Trulicity), produced by Eli Lilly, is agluoagon-like peptide (GLP-1) receptor agonist.

机译：自2015年1月13日起，英国第二次每周两次向2型糖尿病患者注射非胰岛素。礼来（Eli Lilly）生产的缓释dulaglutide（Trulicity）是一种胰高血糖素样肽（GLP-1）受体激动剂。

著录项

来源
《The pharmaceutical journal》 |2015年第7845期|共1页
作者
The pharmaceutical journal group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. DULAGLUTIDE LAUNCHED IN THE UK AS DIABETES TREATMENT [J] . The pharmaceutical journal group The pharmaceutical journal . 2015,第7845期

机译：DULAGLUTIDE在糖尿病治疗中在英国上市
2. Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program [J] . Johan Jendle, George Grunberger, Thomas Blevins, Diabetes/metabolism research and reviews . 2016,第8期

机译：杜拉格兰蛋白质治疗2型糖尿病患者的疗效和安全性：全面审查达尔加勒德临床数据，重点是奖励第3期临床试验计划
3. PREFERENCES FOR TREATMENT ATTRIBUTES OF DULAGLUTIDE AND LIRAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THEIR WILLINGNESS TO SELF-INJECT DIABETES MEDICATION: A COMPARISON BETWEEN JAPAN AND THE UNITED KINGDOM [J] . Gelhorn H. L., Bacci E. D., Poon J. L., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：2型糖尿病患者的DULAGLUIDE和LIRAGLUTIDE的治疗属性及其对糖尿病自我治疗的意愿：日本与英国的比较
4. Adaptive Workflows for Diabetes Management: Self-Management Assistant and Remote Treatment for Diabetes [C] . Ivan CONTRERAS, Stephan KIEFER, Josep VEHI International Conference on Wearable Micro and Nano Technologies for Personalized Health . 2017

机译：糖尿病管理的自适应工作流程：糖尿病的自我管理助理和遥控
5. The relationships among knowledge of diabetes, attitude toward diabetes, family and friends' support, benefits of and barriers to treatment and compliance with health regimens of Jordanian adolescents with insulin dependent diabetes mellitus. [D] . Al-Akour, Nemeh Ahmad. 2003

机译：糖尿病知识，对糖尿病的态度，家人和朋友的支持，受益和治疗障碍以及遵守胰岛素依赖型糖尿病的约旦青少年保健方案之间的关系。
6. Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK [O] . Adie Viljoen, Christina S. Hoxer, Pierre Johansen, -1

机译：在英国评估每周一次塞马鲁肽与度拉鲁肽治疗2型糖尿病的长期成本效益
7. PDB50 Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective [O] . Charokopou M, Chuang L, Verheggen B, 2015

机译：艾塞那肽每周一次与杜拉鲁肽，利拉鲁肽和利西拉来肽治疗2型糖尿病的PDB50成本-效果分析：从英国NHS角度进行的分析

DULAGLUTIDE LAUNCHED IN THE UK AS DIABETES TREATMENT

摘要

著录项

相似文献

相关主题

期刊订阅